SCHEMBL4148317

SCHEMBL4148317

O=C(O)c1ccccc1C=C1SC(=S)N(Cc2ccc3c(c2)OCO3)C1=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 2/20 0.65
▸ DDX3X O00571 1/20 0.59
▸ DUSP22 Q9NRW4 1/20 0.53
▸ ENPP2 Q13822 1/20 0.52
▸ KMT2A Q03164 8/20 0.52
▸ MEN1 O00255 7/20 0.52
▸ NSD2 O96028 1/20 0.52
▸ HSP90AA1 P07900 1/20 0.52
▸ APOBEC3G Q9HC16 1/20 0.52
▸ ALDH1A1 P00352 2/20 0.51
▸ MAPT P10636 2/20 0.51
▸ PTPN1 P18031 1/20 0.50
▸ PTPN7 P35236 1/20 0.49
▸ PTPN12 Q05209 1/20 0.49
▸ GPR35 Q9HC97 1/20 0.49
▸ PTPN22 Q9Y2R2 1/20 0.49
▸ POLB P06746 3/20 0.49
▸ CTDSP1 Q9GZU7 2/20 0.49
▸ BLM P54132 1/20 0.49
▸ NLRP3 Q96P20 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4148315 1.00 MAPK1 (0.65) MAPK1DDX3XDUSP22ENPP2KMT2A
SCHEMBL4014803 0.87 MAPK1 (0.65) MAPK1DDX3XKMT2AMEN1NSD2
SCHEMBL4016080 0.87 MAPK1 (0.65) MAPK1DDX3XKMT2AMEN1NSD2
SCHEMBL4016078 0.87 MAPK1 (0.65) MAPK1DDX3XKMT2AMEN1NSD2
SCHEMBL4138006 0.85 MAPK1 (0.65) MAPK1DDX3XDUSP22KMT2AMEN1
SCHEMBL4138004 0.85 MAPK1 (0.65) MAPK1DDX3XDUSP22KMT2AMEN1
SCHEMBL4125637 0.83 PTPN1 (0.67) MAPK1DDX3XDUSP22KMT2AMEN1
SCHEMBL4125640 0.83 PTPN1 (0.67) MAPK1DDX3XDUSP22KMT2AMEN1
SCHEMBL4125259 0.83 MEN1 (0.65) MAPK1DDX3XDUSP22ENPP2KMT2A
SCHEMBL4125257 0.83 MEN1 (0.65) MAPK1DDX3XDUSP22ENPP2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS KOTNIK MIHA 2009-10-01 — — US disclosed
EP-1916249-A1 3-(benzo[d][1,3]dioxol-5-ylmethyl)-4-(thio)oxo-2-(thio)oxo-azolidin-5-ylidene derivatives as antibacterial agents LEK Pharmaceuticals D.D. (SI) 2008-04-30 — — EP disclosed
WO-2008043733-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS LEK PHARMACEUTICAL D.D. (SI) 2008-04-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090247516-A1 3- (BENZO [D] [1,3] DIOXOL-5-YLMETHYL) -4- (THIO) OXO-2- (THIO) OXO-AZOLIDIN-5-YLIDENE DERIVATIVES AS ANTIBACTERIAL AGENTS XDH, TXLNA, Q6ZSR9 MAPK1 3035/4885DDX3X 348/4885DUSP22 4041/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback